Antibiotic Use Among Hospitalized Patients With COVID-19 in the United States, March 2020-June 2022

Christine Kim; Hannah Wolford; James Baggs; Sujan Reddy; Lauri A Hicks; Melinda M Neuhauser; Sarah Kabbani

doi:10.1093/ofid/ofad503

Antibiotic Use Among Hospitalized Patients With COVID-19 in the United States, March 2020-June 2022

Open Forum Infect Dis. 2023 Oct 7;10(11):ofad503. doi: 10.1093/ofid/ofad503. eCollection 2023 Nov.

Authors

Christine Kim¹, Hannah Wolford¹, James Baggs¹, Sujan Reddy¹, Lauri A Hicks¹, Melinda M Neuhauser¹, Sarah Kabbani¹

Affiliation

¹ Division of Healthcare Quality Promotion, National Center for Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

We conducted a retrospective study to describe antibiotic use among US adults hospitalized with a COVID-19 diagnosis. Despite a decrease in overall antibiotic use, most patients hospitalized with COVID-19 received antibiotics on admission (88.1%) regardless of critical care status, highlighting that more efforts are needed to optimize antibiotic therapy.

Keywords: COVID-10; antibiotic use; antimicrobial stewardship; epidemiology.

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.